These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21343396)

  • 1. CNT1 expression influences proliferation and chemosensitivity in drug-resistant pancreatic cancer cells.
    Bhutia YD; Hung SW; Patel B; Lovin D; Govindarajan R
    Cancer Res; 2011 Mar; 71(5):1825-35. PubMed ID: 21343396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family.
    Skrypek N; Duchêne B; Hebbar M; Leteurtre E; van Seuningen I; Jonckheere N
    Oncogene; 2013 Mar; 32(13):1714-23. PubMed ID: 22580602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective hCNT1 transport contributes to gemcitabine chemoresistance in ovarian cancer subtypes: overcoming transport defects using a nanoparticle approach.
    Hung SW; Marrache S; Cummins S; Bhutia YD; Mody H; Hooks SB; Dhar S; Govindarajan R
    Cancer Lett; 2015 Apr; 359(2):233-40. PubMed ID: 25600708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleoside transporter profiles in human pancreatic cancer cells: role of hCNT1 in 2',2'-difluorodeoxycytidine- induced cytotoxicity.
    García-Manteiga J; Molina-Arcas M; Casado FJ; Mazo A; Pastor-Anglada M
    Clin Cancer Res; 2003 Oct; 9(13):5000-8. PubMed ID: 14581375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells.
    Liu M; Zhang Y; Yang J; Cui X; Zhou Z; Zhan H; Ding K; Tian X; Yang Z; Fung KA; Edil BH; Postier RG; Bronze MS; Fernandez-Zapico ME; Stemmler MP; Brabletz T; Li YP; Houchen CW; Li M
    Gastroenterology; 2020 Feb; 158(3):679-692.e1. PubMed ID: 31711924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo.
    Cao J; Yang J; Ramachandran V; Arumugam T; Deng D; Li Z; Xu L; Logsdon CD
    PLoS One; 2015; 10(12):e0144969. PubMed ID: 26709920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OncomiRs miR-106a and miR-17 negatively regulate the nucleoside-derived drug transporter hCNT1.
    Boces-Pascual C; Mata-Ventosa A; Martín-Satué M; Boix L; Gironella M; Pastor-Anglada M; Pérez-Torras S
    Cell Mol Life Sci; 2021 Dec; 78(23):7505-7518. PubMed ID: 34647142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine promotes epithelial to mesenchymal transition and gemcitabine resistance via hENT1/RRM1 signalling in pancreatic cancer and chemosensitizing effects of Embelin-a naturally occurring benzoquinone.
    Prashanth N ; Meghana P ; Sandeep Kumar Jain R ; Pooja S Rajaput ; Satyanarayan N D ; Raja Naika H ; Kumaraswamy H M
    Sci Total Environ; 2024 Mar; 914():169727. PubMed ID: 38163613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heptadecanoic Acid, an Odd-Chain Fatty Acid, Induces Apoptosis and Enhances Gemcitabine Chemosensitivity in Pancreatic Cancer Cells.
    Kim HY; Moon JY; Cho SK
    J Med Food; 2023 Mar; 26(3):201-210. PubMed ID: 36716276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cells.
    Duong HQ; Hwang JS; Kim HJ; Kang HJ; Seong YS; Bae I
    Int J Oncol; 2012 Sep; 41(3):855-61. PubMed ID: 22710732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential processing of let-7a precursors influences RRM2 expression and chemosensitivity in pancreatic cancer: role of LIN-28 and SET oncoprotein.
    Bhutia YD; Hung SW; Krentz M; Patel D; Lovin D; Manoharan R; Thomson JM; Govindarajan R
    PLoS One; 2013; 8(1):e53436. PubMed ID: 23335963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of fused-pyrimidine nucleoside analogs with human concentrative nucleoside transporters: High-affinity inhibitors of human concentrative nucleoside transporter 1.
    Damaraju VL; Smith KM; Mowles D; Nowak I; Karpinski E; Young JD; Robins MJ; Cass CE
    Biochem Pharmacol; 2011 Jan; 81(1):82-90. PubMed ID: 20854794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells.
    Duong HQ; Yi YW; Kang HJ; Bae I; Jang YJ; Kwak SJ; Seong YS
    Int J Oncol; 2014 Jun; 44(6):2132-8. PubMed ID: 24676703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic Anticancer Effects of Gemcitabine with Pitavastatin on Pancreatic Cancer Cell Line MIA PaCa-2 in vitro and in vivo.
    Chen YH; Chen YC; Lin CC; Hsieh YP; Hsu CS; Hsieh MC
    Cancer Manag Res; 2020; 12():4645-4665. PubMed ID: 32606957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The flavonoid p-hydroxycinnamic acid exhibits anticancer effects in human pancreatic cancer MIA PaCa-2 cells in vitro: Comparison with gemcitabine.
    Yamaguchi M; Murata T; El-Rayes BF; Shoji M
    Oncol Rep; 2015 Dec; 34(6):3304-10. PubMed ID: 26397991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentrative nucleoside transporter 1 (hCNT1) promotes phenotypic changes relevant to tumor biology in a translocation-independent manner.
    Pérez-Torras S; Vidal-Pla A; Cano-Soldado P; Huber-Ruano I; Mazo A; Pastor-Anglada M
    Cell Death Dis; 2013 May; 4(5):e648. PubMed ID: 23722537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conserved residues F316 and G476 in the concentrative nucleoside transporter 1 (hCNT1) affect guanosine sensitivity and membrane expression, respectively.
    Lai Y; Lee EW; Ton CC; Vijay S; Zhang H; Unadkat JD
    Am J Physiol Cell Physiol; 2005 Jan; 288(1):C39-45. PubMed ID: 15456697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance protein 5 affects cell proliferation, migration and gemcitabine sensitivity in pancreatic cancer MIA Paca‑2 and PANC‑1 cells.
    He J; Bugde P; Li J; Biswas R; Li S; Yang X; Tian F; Wu Z; Li Y
    Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37975256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the high-affinity fluoropyrimidine-preferring nucleoside transporter hCNT1 correlates with decreased disease-free survival in breast cancer.
    Gloeckner-Hofmann K; Guillén-Gómez E; Schmidtgen C; Porstmann R; Ziegler R; Stoss O; Casado FJ; Rüschoff J; Pastor-Anglada M
    Oncology; 2006; 70(3):238-44. PubMed ID: 16837820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The xc- cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance.
    Lo M; Ling V; Wang YZ; Gout PW
    Br J Cancer; 2008 Aug; 99(3):464-72. PubMed ID: 18648370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.